Palisade Bio (PALI) Cash & Current Investments (2010 - 2026)
Palisade Bio (PALI) reported Cash & Current Investments of $129.6 million for Q1 2026, up 1692.12% year-over-year from $7.2 million in Q1 2025, and down 2.14% quarter-over-quarter from $132.4 million in Q4 2025.
Palisade Bio (PALI) Cash & Current Investments (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Cash & Current Investments data on file, last reported at $129.6 million in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $129.6 million, up 1692.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $129.6 million (up 1692.12% YoY), and the FY2025 annual result was $132.4 million, up 1256.13% from the prior year.
- Cash & Current Investments retreated to $129.6 million in Q1 2026 per PALI's latest filing, from $132.4 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $132.4 million in Q4 2025 and troughed at $5.0 million in Q2 2022.
- A 5-year average of $24.5 million and a median of $11.4 million in 2024 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2022 and 2026: Cash & Current Investments slumped 60.64% in 2022, then jumped 1692.12% in 2026.
- A 5-year view of Cash & Current Investments shows it stood at $12.4 million in 2022, then gained by 0.4% to $12.4 million in 2023, then slipped by 21.47% to $9.8 million in 2024, then jumped by 1256.13% to $132.4 million in 2025, then decreased by 2.14% to $129.6 million in 2026.
- Business Quant data shows PALI's Cash & Current Investments at $129.6 million in Q1 2026, $132.4 million in Q4 2025, and $5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | 129.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.57 Mn |
| Dec 31, 2025 | 132.40 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Jun 30, 2025 | 5.42 Mn |
| Mar 31, 2025 | 7.23 Mn |
| Dec 31, 2024 | 9.76 Mn |
| Sep 30, 2024 | 8.04 Mn |
| Jun 30, 2024 | 11.35 Mn |
| Mar 31, 2024 | 11.28 Mn |
| Dec 31, 2023 | 12.43 Mn |
| Sep 30, 2023 | 15.31 Mn |
| Jun 30, 2023 | 16.40 Mn |
| Mar 31, 2023 | 13.30 Mn |
| Dec 31, 2022 | 12.38 Mn |
| Sep 30, 2022 | 13.99 Mn |
| Jun 30, 2022 | 4.98 Mn |
| Mar 31, 2022 | 6.64 Mn |
| Dec 31, 2021 | 10.50 Mn |
| Sep 30, 2021 | 14.10 Mn |
| Jun 30, 2021 | 12.65 Mn |